An innovative new process, apheresis involves the filtering and removal of blood components meaning that seriously ill children can receive potentially life saving care.
Apheresis can be used to assist with the care of patients across the hospital, including those undergoing stem cell transplants, sickle cell disease and leukaemia treatment, and to assist with the management of organ rejection or dysfunction following transplantation.
Apheresis provides critically ill children access to both standard and new innovative and cutting edge treatments, offering those with previously incurable cancers and established therapy to battle the disease.
Thanks to the Good Friday Appeal, the ability to access on-demand apheresis therapies will also mean that acutely ill children, for example those at risk of strong and multi-organ failure, can receive this life-saving emergency care.
Posted May 2020